Buto Corp
Home
About Us
Pipeline
Contact Us
Buto Corp
Home
About Us
Pipeline
Contact Us
More
  • Home
  • About Us
  • Pipeline
  • Contact Us
  • Home
  • About Us
  • Pipeline
  • Contact Us

Potent Inhibitors of Fibrotic Disease

Potent Inhibitors of Fibrotic DiseasePotent Inhibitors of Fibrotic DiseasePotent Inhibitors of Fibrotic DiseasePotent Inhibitors of Fibrotic Disease

 Scientific Breakthroughs in Fibrosis and Alzheimer's Disease

Learn More

Potent Inhibitors of Fibrotic Disease

Potent Inhibitors of Fibrotic DiseasePotent Inhibitors of Fibrotic DiseasePotent Inhibitors of Fibrotic DiseasePotent Inhibitors of Fibrotic Disease

 Scientific Breakthroughs in Fibrosis and Alzheimer's Disease

Learn More

Bringing Change to Fibrotic and Alzheimer's disease

Buto has a unique therapeutic focus, to block pathophysiologic transitions that occur in a number of fibrotic diseases, and in Alzheimer’s disease. Our molecules have demonstrated efficacy in animal and human fibrosis, and in animal models of Alzheimer's disease.

Our Target - the Shc protein

Buto has uniquely in the world developed small molecules that target the Shc protein—no other company has targeted this molecule.  Shc is a ‘gatekeeper protein’ that modulates cell differentiation and pathophysiological transitions.

Further Questions?

Please visit our contact page for any questions or inquiries.

Find out more

Copyright © 2022 Buto Corp - All Rights Reserved.

  • Home
  • About Us
  • Pipeline
  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept